Intranasal peptide contraception by inhibition of ovulation with the gonadotropin-releasing hormone superagonist nafarelin: six months' clinical results
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 45 (5) , 617-623
- https://doi.org/10.1016/s0015-0282(16)49331-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRHContraception, 1984
- Peptide Contraception in WomenUpsala Journal of Medical Sciences, 1984
- Synthesis and biological activity of some very hydrophobic superagonist analogs of luteinizing hormone-releasing hormoneJournal of Medicinal Chemistry, 1982
- Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?Contraception, 1981
- Recent Approaches to Fertility Control Based on Derivatives of LH-RHPublished by Elsevier ,1981
- Ovulation inhibition by daily I.M. Administration of a highly active LH-RH analog (D-ser(TBU)6-LH-RH-(1–9)-nonapeptide-ethylamide)Contraception, 1980
- Aspects of Hypothalamic Regulation of the Pituitary GlandScience, 1978
- The Statistical Analysis of Menstrual Bleeding PatternsJournal of Biosocial Science, 1977
- Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroidsContraception, 1972
- Time Course of Serum Estrogen and Luteinizing Hormone (LH) Concentrations During the Menstrual Cycle of the Rhesus MonkeyEndocrinology, 1971